Metraipolis › archive › dc_beeab409049d

Comparative safety signals of carboplatin and cisplatin in lung cancer: a pharmacovigilance study based on FAERS — Europe PMC PMID:42558823

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42558823
DOI
10.3389/fmed.2026.1846025
License (as archived)
solo-consultazione
Archived
2026-10-17T23:55:19.192Z
SHA-256 of the archived text
6360a2890d3082113b8e09bf28cc67aa89a349f348efcd5aaaa5c31e267173a5
Stable URL of this page
https://metraipolis.com/documento/dc_beeab409049d

How to cite

Comparative safety signals of carboplatin and cisplatin in lung cancer: a pharmacovigilance study based on FAERS — Europe PMC PMID:42558823 — Europe PMC (en), https://europepmc.org/article/MED/42558823 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_beeab409049d (Metraipolis archive dc_beeab409049d, sha256 6360a2890d3082113b8e09bf28cc67aa89a349f348efcd5aaaa5c31e267173a5)
BibTeX
@misc{dcbeeab409049d,
  title = {Comparative safety signals of carboplatin and cisplatin in lung cancer: a pharmacovigilance study based on FAERS — Europe PMC PMID:42558823},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42558823},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_beeab409049d; sha256 6360a2890d3082113b8e09bf28cc67aa89a349f348efcd5aaaa5c31e267173a5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42558823. Agents can read the archived copy with the MCP tool read_document.